US FDA approves Gilead's COVID-19 drug for young children
April 26, 2022 at 09:38 AM EDT
The FDA has granted full approval to Gilead's remdesivir COVID-19 treatment for children 28 days and older.
|
||||||||||||
![]() |
||||||||||||
|
||||||||||||
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map |